1. A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomas. (17th October 2018) Authors: Gehlhausen, Jeffrey R; Hawley, Eric; Wahle, Benjamin Mark; He, Yongzheng; Edwards, Donna; Rhodes, Steven D; Lajiness, Jacquelyn D; Staser, Karl; Chen, Shi; Yang, Xianlin; Yuan, Jin; Li, Xiaohong; Jiang, Li; Smith, Abbi; Bessler, Waylan; Sandusky, George; Stemmer-Rachamimov, Anat; Stuhlmiller, Tim... Journal: Human molecular genetics Issue: Volume 28:Number 4(2019) Page Start: 572 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. NFM-09. PRELIMINARY REPORT OF A MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY. Issue 2 (22nd June 2018) Authors: Tonsgard, James; Ullrich, Nicole; Blakeley, Jaishri; Rosser, Tena; Packer, Roger; Korf, Bruce; Fisher, Michael; Cutter, Gary; Plotkin, Scott; Karajannis, Matthias; Allen, Jeffrey; Wade Clapp, D; Thomas, Coretta; Campian, Jian Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗